Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Randomized, Open-Label Study to Evaluate the Efficacy and Safety of PMX Cartridge in Addition to Standard Medical Care for Patients With Endotoxemic Septic Shock

NCT03901807 is registered in ClinicalTrials.gov with Spectral Diagnostics (US) Inc. as lead sponsor.

NCT NCT03901807
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03901807 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Randomized, Open-Label Study to Evaluate the Efficacy and Safety of PMX Cartridge in Addition to Standard Medical Care for Patients With Endotoxemic Septic Shock
Lead sponsor
Spectral Diagnostics (US) Inc.
Phase
Not applicable
Overall status
Completed
Start date
January 9, 2020
Completion date
February 10, 2026
Enrollment
157 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

endotoxemia, septic shock